CHE vs TMO · P/E 24, rev $2.43B vs P/E 24, rev $44.56B
Chemed Corp (CHE) versus Thermo Fisher Scientific Inc (TMO) — a side-by-side from cached financials, not a winner call.
Chemed Corp (CHE) is a medical care facilities company listed on NYSE.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
Latest reported CHE revenue for 2024-12-31 was $2.43B. Net income was $302.0M. Revenue was up 7.4% from 2023-12-31 to 2024-12-31. CHE currently screens at market cap $5.79B and trailing P/E 23.8.
Latest reported TMO revenue for 2025-12-31 was $44.56B. Net income was $6.70B. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
CHE currently screens at market cap $5.79B and trailing P/E 23.8. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Not investment advice. Open the CHE and TMO stock pages for the full models.
Not investment advice.